Literature DB >> 10348799

Effect of leptin on cytochrome P-450, conjugation, and antioxidant enzymes in the ob/ob mouse.

A M Watson1, S M Poloyac, G Howard, R A Blouin.   

Abstract

Leptin is a hormone that is secreted by adipocytes and regulates body weight through its effect on satiety and energy metabolism. The ob/ob mouse is deficient in this protein and is characterized by obesity and other metabolic disorders. This study investigated the alterations of several hepatic cytochrome P-450 (CYP), conjugation, and antioxidant enzymes in lean and ob/ob mice and the role leptin plays in the modulation of these enzymes. Lean and ob/ob male mice were injected with leptin (100 microg) or PBS for 15 days. Liver microsomes from ob/ob mice, when compared with lean controls, displayed significantly reduced chlorzoxazone 6-hydroxylation activity (27%); however, 7alpha- and 16alpha- testosterone hydroxylation and pentoxyresorufin O-dealkylation activities were significantly higher (47%, 22%, and 39%, respectively). Leptin administration corrected alterations seen with all P-450 activities. Dealkylation of ethoxyresorufin and omega-hydroxylation of lauric acid activities from ob/ob and lean mice were not statistically different; however, leptin exposure significantly increased ethoxyresorufin activity in lean mice (14%) and decreased the activity in ob/ob mice (36%). UDP-glucuronosyl-transferase and glutathione S-transferase activities were not altered. The antioxidant enzymes, catalase (11%) and glutathione peroxidase (26%), as well as glutathione reductase (17%), were lower in the ob/ob mice and leptin treatment corrected these alterations. The results of this study demonstrate alterations in constitutive expression of CYP2B, CYP2E, CYP2A, catalase, glutathione peroxidase, and glutathione reductase in ob/ob mice that were restored to lean control values following leptin treatment. Additionally, CYP3A activity was increased following leptin treatment in ob/ob mice. The mechanism for the observed alterations may be due to direct leptin effects or via indirect alterations in insulin, corticosterone, and/or growth hormone.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10348799

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  17 in total

1.  Decreased exposure of simvastatin and simvastatin acid in a rat model of type 2 diabetes.

Authors:  Dan Xu; Feng Li; Mian Zhang; Ji Zhang; Can Liu; Meng-yue Hu; Ze-yu Zhong; Ling-ling Jia; Da-wei Wang; Jie Wu; Li Liu; Xiao-dong Liu
Journal:  Acta Pharmacol Sin       Date:  2014-08-25       Impact factor: 6.150

Review 2.  Leptin and cardiovascular disease: response to therapeutic interventions.

Authors:  Kwang Kon Koh; Sang Min Park; Michael J Quon
Journal:  Circulation       Date:  2008-06-24       Impact factor: 29.690

Review 3.  Drug metabolism alterations in nonalcoholic fatty liver disease.

Authors:  Matthew D Merrell; Nathan J Cherrington
Journal:  Drug Metab Rev       Date:  2011-05-25       Impact factor: 4.518

4.  Enalapril reverses high-fat diet-induced alterations in cytochrome P450-mediated eicosanoid metabolism.

Authors:  Katherine N Theken; Yangmei Deng; Robert N Schuck; Akinyemi Oni-Orisan; Tricia M Miller; M Alison Kannon; Samuel M Poloyac; Craig R Lee
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-12-20       Impact factor: 4.310

Review 5.  Non-Alcoholic Fatty Liver Disease, an Overview.

Authors:  Asia Muhammad Nd
Journal:  Integr Med (Encinitas)       Date:  2019-04

6.  Obesity Decreases Hepatic 25-Hydroxylase Activity Causing Low Serum 25-Hydroxyvitamin D.

Authors:  Jeffrey D Roizen; Caela Long; Alex Casella; Lauren O'Lear; Ilana Caplan; Meizan Lai; Issac Sasson; Ravinder Singh; Andrew J Makowski; Rebecca Simmons; Michael A Levine
Journal:  J Bone Miner Res       Date:  2019-02-21       Impact factor: 6.741

7.  Hepatic CYP3A expression is attenuated in obese mice fed a high-fat diet.

Authors:  Kouichi Yoshinari; Shunsuke Takagi; Teruyasu Yoshimasa; Junko Sugatani; Masao Miwa
Journal:  Pharm Res       Date:  2006-05-25       Impact factor: 4.200

8.  Effects of rosiglitazone treatment on the pentose phosphate pathway and glutathione-dependent enzymes in liver and kidney of rats fed a high-fat diet.

Authors:  Esen Akbay; Nuriye Nuray Ulusu; Füsun Töröner; Göksun Ayvaz; Ferit Taneri; Müjde Aktürk; Metin Arslan; Cimen Karasu
Journal:  Curr Ther Res Clin Exp       Date:  2004-01

9.  Leptin administration downregulates the increased expression levels of genes related to oxidative stress and inflammation in the skeletal muscle of ob/ob mice.

Authors:  Neira Sáinz; Amaia Rodríguez; Victoria Catalán; Sara Becerril; Beatriz Ramírez; Javier Gómez-Ambrosi; Gema Frühbeck
Journal:  Mediators Inflamm       Date:  2010-06-30       Impact factor: 4.711

10.  The role of novel biomarkers of cardiovascular disease in chronic kidney disease: focus on adiponectin and leptin.

Authors:  Omar M Kaisar; David W Johnson; Judith B Prins; Nicole Isbel
Journal:  Curr Cardiol Rev       Date:  2008-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.